BioLineRx Ltd. SEC filings BLRX
BioLineRx Ltd. has 617 filings in SEC EDGAR's recent list, going back to Sep 24, 2010. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 23, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 2, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Sep 25, 2026 | — |
| 424B5 | Prospectus supplement | Aug 31, 2026 | — |
| S-8 | Employee stock plan registration | Jan 23, 2026 | — |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| 424B5 | Prospectus supplement | Apr 11, 2025 | — |
| 424B5 | Prospectus supplement | Jan 7, 2025 | — |
| S-8 | Employee stock plan registration | Dec 27, 2024 | — |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | Apr 1, 2024 | — |
| S-8 | Employee stock plan registration | Dec 29, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 29, 2023 | — |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| 424B5 | Prospectus supplement | Sep 20, 2022 | — |
| 424B5 | Prospectus supplement | Sep 3, 2021 | — |
| POS AM | Filing | Feb 23, 2021 | — |
| 424B5 | Prospectus supplement | Jan 21, 2021 | — |
| FWP | Free writing prospectus | Jan 20, 2021 | — |
| FWP | Free writing prospectus | Jan 19, 2021 | — |
| 424B5 | Prospectus supplement | Jan 19, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 31, 2020 | — |
| 424B5 | Prospectus supplement | Dec 31, 2020 | — |
| 424B5 | Prospectus supplement | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Sep 25, 2020 | — |
| POS AM | Filing | Aug 7, 2020 | — |
| 424B3 | Prospectus | Jul 2, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jun 26, 2020 | — |
| 424B5 | Prospectus supplement | Jun 3, 2020 | — |
| 424B5 | Prospectus supplement | May 28, 2020 | — |
| 424B5 | Prospectus supplement | Apr 17, 2020 | — |
| 424B5 | Prospectus supplement | Feb 5, 2019 | — |
| 424B5 | Prospectus supplement | Feb 4, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 26, 2018 | — |
| 424B5 | Prospectus supplement | Jan 19, 2018 | — |
| F-3/A | Filing | Jan 19, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 28, 2017 | — |
| 424B5 | Prospectus supplement | Oct 31, 2017 | — |
| 424B5 | Prospectus supplement | Jul 26, 2017 | — |
| 424B5 | Prospectus supplement | Apr 3, 2017 | — |
| 424B5 | Prospectus supplement | Mar 30, 2017 | — |
| S-8 POS | S-8 | Mar 29, 2017 | — |
| S-8 | Employee stock plan registration | Jan 5, 2016 | — |
| F-3/A | Filing | Oct 16, 2015 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 16, 2015 | — |
| 424B3 | Prospectus | Jun 8, 2015 | — |
| 424B3 | Prospectus | Jun 8, 2015 | — |
| 424B5 | Prospectus supplement | Mar 6, 2015 | — |
| 424B5 | Prospectus supplement | Mar 5, 2015 | — |
| S-8 | Employee stock plan registration | Dec 31, 2014 | — |
| 424B2 | Prospectus | Jun 13, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | May 30, 2014 | — |
| 424B5 | Prospectus supplement | Mar 4, 2014 | — |
| 424B5 | Prospectus supplement | Mar 3, 2014 | — |
| 424B5 | Prospectus supplement | Mar 3, 2014 | — |
| 424B3 | Prospectus | Aug 8, 2013 | — |
| POS AM | Filing | Jul 26, 2013 | — |
| 424B5 | Prospectus supplement | May 17, 2013 | — |
| 424B5 | Prospectus supplement | May 17, 2013 | — |
| 424B5 | Prospectus supplement | Feb 6, 2013 | — |
| 424B3 | Prospectus | Oct 15, 2012 | — |
| F-1/A | Filing | Oct 12, 2012 | — |
| F-1 | Registration statement (foreign issuer) | Oct 2, 2012 | — |
| S-8 | Employee stock plan registration | Sep 19, 2012 | — |
| F-3/A | Filing | Aug 13, 2012 | — |
| F-3/A | Form f-3 registration statement | Aug 10, 2012 | — |
| 424B3 | Prospectus | Aug 2, 2012 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 1, 2012 | — |
| POS AM | Filing | Jul 25, 2012 | — |
| F-3/A | Amendment no.2 on form f-3 to registration statement on form f-1 | Jul 23, 2012 | — |
| 424B3 | Prospectus | Mar 28, 2012 | — |
| F-1/A | Filing | Mar 26, 2012 | — |
| F-1 | Registration statement (foreign issuer) | Feb 29, 2012 | — |
| S-8 | Employee stock plan registration | Aug 22, 2011 | — |
| F-6 | Form f-6 | Jul 6, 2011 | — |
| F-1 | Registration statement (foreign issuer) | Sep 24, 2010 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Modi-In
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1498403
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.